CPT_MOD|CPT_MOD_DESC
0A|BRCA1 (Hereditary breat/Ovarian cancer)
0B|BRCA2 (Hereditary breast cancer)
0C|Neurofibromin (Neurofibromatosis, type 1)
0D|Merlin (Neurofibromatosis, type 2)
0E|c-RET (Multiple endrocrine neoplasia, types 2A/B, familial medullary thyroid carcinoma)
0F|VHL (Von Hippel Lindau desease, renal carcinoma)
0G|SDHD (Hereditary paraganglioma)
0H|SDHB (Hereditary paraganglioma)
0I|ERRB2, commonly called Her-2/neu
0J|MLH1 (HNPCC, mismatch repair genes)
0K|MSH2, MSH6, or PMS2 (HNPCC, mismatch repair genes)
0L|APC (Hereditary polyposis coli)
0M|Rb (Retinoblastoma)
0N|TP53, commonly called p53
0O|PTEN (Cowden's syndrome)
0P|KIT, also called CD117 (gastrointestinal stromal tumor)
0Z|Solid tumor gene, not otherwise specified
1A|WT1 or WT2 (Wilm's tumor)
1B|PAX3, PAX7, or FOX01A (Alveolar rhabdomyosarcoma)
1C|FLI1, ERG, ETV1, or EWSR1 (Ewing's sarcoma, desmoplastic round cell)
1D|DDIT3 or FUS (Myxoid liposarcoma)
1E|NR4A3, RBF56, or TCF12 (Myxoid chondrosarcoma)
1F|SSX1, SSX2, or SYT (Synovial sarcoma)
1G|MYCN (Neuroblastoma)
1H|COL1A1 or PDGFB (Dermato--fibrosarcoma protuberans)
1I|TFE3 or ASPSCR1 (Alveolar soft parts sarcoma)
1J|JAZF1 or JJAZ1 (Endometrial stromal sarcoma)
1Z|Sarcoma gene, not otherwise specified
21|Prolonged E&M Services
22|Increased Procedural Services
23|Unusual Anesthesia
24|Unrelated E&M Service by the Same Physician During a Postoperative Period
25|Significant, Separately Identifiable E&M Service by the Same Physician on the Same Day of a Procedure or Other Service
26|Professional Component
27|Multiple Outpatient Hospital E/M Encounters on the Same Date
2A|RUNX1 or CBFA2T1, commonly called AML1 or ETO, genes associated with t(8;21) AML1 - also ETO (Acute myelogenous leukemia)
2B|BCR or ABL1, genes associated with t(9;22) (Chronic myelogenous or acute leukemia) BCR - also ABL (Chronic myeloid, acute lymphoid leukemia)
2C|PBX1 or TCF3, genes associated with t(1;19) (Acute lymphoblastic leukemia) CGF1
2D|CBFB or MYH11, genes associated with inv 16 (Acute myelogenous leukemia) CBF beta (leukemia)
2E|MLL (acute leukemia)
2F|PML or RARA, genes associated with t(15;17) (Acute promyelocytic leukemia) PML/RAR alpha (Promyelocytic leukemia)
2G|ETV6, commonly called TEL, gene associated with t(12;21) (acute leukemia) TEL (Leukemia)
2H|BCL2 (B cell hymphoma, follicle center cell origin) bcl-2 (Lymphoma)
2I|CCND1, commonly called BCL1, cyclin D1 (Mantle cell lymphoma, myeloma) bcl-1 (Lymphoma)
2J|MYC (Burkitt lymphoma) c-myc (Lymphoma)
2K|lgH (Lymphoma/leukemia)
2L|IGK (Lymphoma/leukemia)
2M|TRB, T cell receptor beta (Lymphoma/leukemia)
2N|TRG, T cell recoptor gamma (Lymphoma/leukemia)
2O|SIL or TAL1 (T cell leukemia)
2Q|API1 or MALT1 (MALT lymphoma)
2R|NPM or ALK, genes associated with t(2;5) (Anaplastic large cell lymphoma)
2S|FLT3 (Acute myelogenous leukemia)
2T|BCL6 (B cell lymphoma)
2Z|Lymphoid/hematopoietic neoplasia, not otherwise specified
32|Mandated Services
33|Preventive Service
3A|F5, commonly called Factor V (Leiden, others) (Hypercoagulable state)
3B|FACC (Fanconi anemia)
3C|FACD (Fanconi anemia)
3D|HBB, beta globin (Thalassemia, Sickle cell anemia, other hemoglobinopathies)
3E|HBA, commonly called alpha globin (Thalassemia)
3F|MTHFR (Elevated homocystinemia)
3G|F2, commonly called prothrombin (20210, others) (Hypercoagulable state) Prothrombin (Factor II, 20210A) (Hypercoagulable state)
3H|F8, commonly called Factor VIII (Hemophilia A/VWF)
3I|F9, commonly called Factor IX (Hemophilia B)
3K|F13, commonly called Factor XIII (bleeding or hypercoagulable state) Beta globin
3Z|Non-neoplastic hematology/coagulation, not otherwise specified
47|Anesthesia by Surgeon
4A|HLA-A
4B|HLA-B
4C|HLA-C
4D|HLA-D
4E|HLA-DRB all
4F|HLA-DQB1
4G|HLA-DPB1
4H|Kell
4I|Fingerprint for engraftment (post-allogeneic progenitor cell transplant)
4J|Fingerprint for donor allelotype (allogeneic transplant)
4K|Fingerprint for recipient allelotype (allogeneic transplant)
4L|Fingerprint for leukocyte chimerism (allogeneic solid organ transplant)
4M|Fingerprint for maternal versus fetal origin
4N|Microsatellite instability
4O|Microsatellite loss (loss of heterozygosity)
4P|HLA-DRB1
4Q|HLA-DRB3
4R|HLA-DRB4
4S|HLA-DRB5
4T|HLA-DQA1
4U|HLA-DPA1
4Z|Histocompatibilty/blood typing, not otherwise specified
50|Bilateral Procedure
51|Multiple Procedures
52|Reduced Services
53|Discontinued Procedure
54|Surgical Care Only
55|Postoperative Management Only
56|Preoperative Management Only
57|Decision for Surgery
58|Staged or Related Procedure or Service by the Same Physician During the Same Postoperative Period
59|Distinct Procedural Service
5A|ASPA, commonly called Aspartoacylase A (Canavan disease)
5B|FMR-1 (Fragile X, FRAXA, syndrome)
5C|FRDA, commonly called Frataxin (Freidreich ataxia)
5D|HD, commonly called Huntington (Huntington's disease)
5E|GABRA5, NIPA1, UBE3A, or ANCR GABRA (Prader Willi-Angelman syndrome)
5F|GJB2, commonly called Connexin-26 (Hereditary hearing loss) Connexin-32 (GJB2) (Hereditary deafness)
5G|GJB1, commonly called Connexin-32 (X-linked Charcot-Marie-Tooth disease)
5H|SNRPN (Prader Willi-Angelman syndrome)
5I|SCA1, commonly called Ataxin-1 (Spinocerebellar ataxia, type 1)
5J|SCA2, commonly called Ataxin-2 (Spinocerebellar ataxia, type 2)
5K|MJD, commonly called Ataxin-3 (Spinocerebellar ataxia, type 3, Machado-Joseph disease)
5L|CACNA1A (Spinocerebellar ataxia, type 6)
5M|ATXN7 Ataxin-7 (Spinocerebellar ataxia, type 7)
5N|PMP-22 (Charcot-Marie-Tooth disease, type 1A)
5O|MECP2 (Rett syndrome)
5Z|Neurologic, non-neoplastic, not otherwise specified
62|Two Surgeons
63|Procedure Performed on Infants less than 4kg
66|Surgical Team
6A|DMD, commonly called dystrophin (Duchenne/Becker muscular dystrophy)
6B|DMPK (Myotonic dystrophy, type 1)
6C|ZNF-9 (Myotonic dystrophy, type 2)
6D|SMN1/SMN2 (Autosomal recessive spinal muscular atrophy)
6E|MTTK, commonly called tRNAlys (myotonic epilepsy, MERRF)
6F|MTTL1, commonly called tRNAleu (mitochondrial encephalomyopathy, MELAS)
6Z|Muscular, not otherwise specified
73|Discontinued Out-Patient Hospital/Ambulatory Surgery Center (ASC) Procedure Prior to the Administration of Anesthesia
74|Discontinued Out-Patient Hospital/Ambulatory Surgery Center (ASC) Procedure After Administration of Anesthesia
76|Repeat Procedure or Service by Same Physician or Other Qualified Health Care Professional
77|Repeat Procedure by Another Physician or Other Qualified Health Care Professional
78|Unplanned Return to Operating/Procedure Room by the Same Physician or Other Qualified Health Care Professional Following Initial Procedure for a Related Procedure During Postoperative Period
79|Unrelated Procedure or Service by the Same Physician During the Postoperative Period
7A|APOE, commonly called apolipoprotein E (Cardiovascular disease or Alzheimer's disease)
7B|NPC1 or NPC2, commonlyu called sphingomyelin phosphodeisterase (Neiman-Pick disease)
7C|GBA, commonly called acid beta glucosidase (Gaucher disease)
7D|HFE (Hemochromatosis)
7E|HEXA, commonly called hexosaminidase A (Tay-Sachs disease)
7F|ACADM (medium chain acyl CoA dehydrogenase deficiency)
7Z|Metabolic, other, not otherwise specified
80|Assistant Surgeon
81|Minimum Assistant Surgeon
82|Assistant Surgeon (when qualified resident surgeon not available)
8A|CFTR (Cystic fibrosis)
8B|PRSS1 (Hereditary pancreatitis)
8C|Long QT syndrome, KCN (Jervell and Lange-Nielsen syndromes, types 1, 2, 5, and 6) and SCN (Brugada syndrome, SIDS and type 3)
8Z|Metabolic, transport, not otherwise specified
90|Reference (Outside) Laboratory
91|Repeat Clinical Diagnostic Laboratory Test
92|Alternative Laboratory Platform Testing
99|Multiple Modifiers
9A|TPMT, commonly called (thiopurine methyltransferase) (patients on antimetabolite therapy)
9B|CYP2 genes, commonly called cytochrome p450 (drug metabolism)
9C|ABCB1, commonly called MDR1 or p-glycoprotein (drug transport)
9D|NAT2 (drug metabolism)
9L|Metabolic-pharmacogenetics, not otherwise specified
9M|FGFR1 (Pfeiffer and Kallman syndromes)
9N|FGFR2 (Crouzon, Jackson-Weiss, Apert, Saethre-Chotzen syndromes)
9O|FGFR3 (Achondroplasia, Hypochondroplasia, Thanatophoric dysplasia, type I and II, Crouzon syndrome with acanthosis nigricans, Muencke syndromes)
9P|TWIST (Saethre-Chotzen syndrome)
9Q|DGCR, commonly called CATCH-22 (DiGeorge and 22q11 deletion syndromes)
9Z|Dysmorphology, not otherwise specified
A1|DRESSING FOR ONE WOUND
A2|DRESSING FOR TWO WOUNDS
A3|DRESSING FOR THREE WOUNDS
A4|DRESSING FOR FOUR WOUNDS
A5|DRESSING FOR FIVE WOUNDS
A6|DRESSING FOR SIX WOUNDS
A7|DRESSING FOR SEVEN WOUNDS
A8|DRESSING FOR EIGHT WOUNDS
A9|DRESSING FOR 9 OR MORE WOUNDS
AA|ANESTHESIA PERF BY ANESGST
AD|MD SUPERVISION, >4 ANES PROC
AE|REGISTERED DIETICIAN
AF|SPECIALTY PHYSICIAN
AG|PRIMARY PHYSICIAN
AH|CLINICAL PSYCHOLOGIST
AI|PRINCIPAL PHYSICIAN OF RECORD
AJ|CLINICAL SOCIAL WORKER
AK|NON PARTICIPATING PHYSICIAN
AM|PHYSICIAN, TEAM MEMBER SERVICE
AO|PROV DECLINED ALT PMT METHOD
AP|NO DTMN OF REFRACTIVE STATE
AQ|PHYSICIAN PROVIDING A SERVICE IN AN UNLISTED HEALTH PROFESSIONAL SHORTAGE AREA
AR|PHYSICIAN SCARCITY AREA
AS|ASSISTANT AT SURGERY SERVICE
AT|ACUTE TREATMENT
AU|URO, OSTOMY OR TRACH ITEM
AV|ITEM W PROSTHETIC/ORTHOTIC
AW|ITEM W A SURGICAL DRESSING
AX|ITEM W DIALYSIS SERVICES
AY|ITEM/SERVICE NOT FOR ESRD TREATMENT
AZ|PHYSICIAN SERVICE IN DENTAL HPSA
BA|ITEM W PEN SERVICES
BL|SPECIAL ACQUISITION OF BLOOD AND BLOOD PRODUCTS
BO|NUTRITION ORAL ADMIN NO TUBE
BP|BENE ELECTED TO PURCHASE ITEM
BR|BENE ELECTED TO RENT ITEM
BU|BENE UNDECIDED ON PURCH/RENT
CA|PROCEDURE PAYABLE INPATIENT
CB|ESRD BENE PART A SNF-SEP PAY
CC|PROCEDURE CODE CHANGE
CD|AMCC TEST FOR ESRD OR MCP MD
CE|MED NECES AMCC TST SEP REIMB
CF|AMCC TST NOT COMPOSITE RATE
CG|POLICY CRITERIA APPLIED
CH|0 PERCENT IMPAIRED, LTD, RES
CI|1 TO <20 PERCENT IMPAIRED
CJ|20 TO <40 PERCENT IMPAIRED
CK|40 TO <60 PERCENT IMPAIRED
CL|60 TO <80 PERCENT IMPAIRED
CM|80 TO <100 PERCENT IMPAIRED
CN|100 PERCENT IMPAIRED, LTD
CP|C-APC ADJUNCTIVE SERVICE
CR|CATASTROPHE/DISASTER RELATED
CS|GULF OIL 2010 SPILL RELATED
CT|CT DOES NOT MEET NEMA STANDA
DA|ORAL HEALTH ASSESS, NOT DENT
DD|Diagnostic/therapeutic site other than P/H to another Diagnostic/therapeutic site other than P/H
DE|Diagnostic/therapeutic site other than P/H to a Residential/Domiciliary/Custodial fac.
DG|Diagnostic/therapeutic site other than P/H to a Hospital-based Dialysis Facility
DH|Diagnostic/therapeutic site other than P/H to a Hospital
DI|Diagnostic/therapeutic site other than P/H to a Site of ambulance transport modes transfer
DJ|Diagnostic/therapeutic site other than P/H to a Non-Hospital-based Dialysis facility
DN|Diagnostic/therapeutic site other than P/H to a Skilled Nursing Facility (SNF)
DP|Diagnostic/therapeutic site other than P/H to a Physician's office
DR|Diagnostic/therapeutic site other than P/H to a Residence
DS|Diagnostic/therapeutic site other than P/H to a Scene of Accident/Acute Event
DX|Diagnostic/therapeutic site other than P/H to an Intermediate Stop at Physician's Office
E1|UPPER LEFT EYELID
E2|LOWER LEFT EYELID
E3|UPPER RIGHT EYELID
E4|LOWER RIGHT EYELID
EA|ERYTHROPOETIC STIMULATING AGENT (ESA), ANEMIA, CHEMO-INDUCED
EB|ERYTHROPOETIC STIMULATING AGENT (ESA), ANEMIA, RADIO-INDUCED
EC|ERYTHROPOETIC STIMULATING AGENT (ESA), ANEMIA, NON-CHEMO/RADIO
ED|Residential/Domiciliary/Custodial fac. to a Diagnostic/therapeutic site other than P/H
ED|HEMATOCRIT LEVEL HAS EXCEEDED 39% (OR HEMOGLOBIN LEVEL HAS EXCEEDED 13.0 G/DL) >=3 CYCLE
EE|Residential/Domiciliary/Custodial fac. to another Residential/Domiciliary/Custodial fac.
EE|HEMATOCRIT LEVEL HAS NOT EXCEEDED 39% (OR HEMOGLOBIN LEVEL HAS NOT EXCEEDED 13.0G/DL) < 3 CYCLE
EG|Residential/Domiciliary/Custodial fac. to a Hospital-based Dialysis Facility
EH|Residential/Domiciliary/Custodial fac. to a Hospital
EI|Residential/Domiciliary/Custodial fac. to a Site of ambulance transport modes transfer
EJ|Residential/Domiciliary/Custodial fac. to a Non-Hospital-based Dialysis facility
EJ|SUBSEQUENT CLAIM
EM|EMER RESERVE SUPPLY(ESRD)
EN|Residential/Domiciliary/Custodial fac. to a Skilled Nursing Facility (SNF)
EP|Residential/Domiciliary/Custodial fac. to a Physician's office
EP|MEDICAID EPSDT PROGRAM SVC
ER|Residential/Domiciliary/Custodial fac. to a Residence
ES|Residential/Domiciliary/Custodial fac. to a Scene of Accident/Acute Event
ET|EMERGENCY SERVICES
EX|Residential/Domiciliary/Custodial fac. to an Intermediate Stop at Physician's Office
EX|EXPATRIATE BENEFICIARY
EY|NO MD ORDER FOR ITEM/SERVICE
F1|LEFT HAND, SECOND DIGIT
F2|LEFT HAND, THIRD DIGIT
F3|LEFT HAND, FOURTH DIGIT
F4|LEFT HAND, FIFTH DIGIT
F5|RIGHT HAND, THUMB
F6|RIGHT HAND, SECOND DIGIT
F7|RIGHT HAND, THIRD DIGIT
F8|RIGHT HAND, FOURTH DIGIT
F9|RIGHT HAND, FIFTH DIGIT
FA|LEFT HAND, THUMB
FB|ITEM PROVIDED WITHOUT COST TO PROVIDER, SUPPLIER OR PRACTITIONER, OR FULL
FC|PARTIAL CREDIT RECEIVED FOR REPLACED DEVICE
FP|SVC PART OF FAMILY PLAN PGM
G1|URR READING OF LESS THAN 60
G2|URR READING OF 60 TO 64.9
G3|URR READING OF 65 TO 69.9
G4|URR READING OF 70 TO 74.9
G5|URR READING OF 75 OR GREATER
G6|ESRD PATIENT <6 DIALYSIS/MTH
G7|PAYMENT LIMITS DO NOT APPLY
G8|MONITORED ANESTHESIA CARE
G9|MAC FOR AT RISK PATIENT
GA|WAIVER OF LIABILITY ON FILE
GB|CLAIM RESUBMITTED
GC|RESIDENT/TEACHING PHYS SERV
GD|Hospital-based Dialysis Facility to a Diagnostic/therapeutic site other than P/H
GD|UNITS OF SERVICE EXCEEDS MEDICALLY UNLIKELY EDIT VALUE AND REPRESENTS
GE|Hospital-based Dialysis Facility to a Residential/Domiciliary/Custodial fac.
GE|RESIDENT PRIM CARE EXCEPTION
GF|NONPHYSICIAN SERV C A HOSP
GG|Hospital-based Dialysis Facility to another Hospital-based Dialysis Facility
GG|PAYMENT SCREEN MAM + DIAGMAM
GH|Hospital-based Dialysis Facility to a Hospital
GH|DIAG MAMMO TO SCREENING MAMO
GI|Hospital-based Dialysis Facility to a Site of ambulance transport modes transfer
GJ|Hospital-based Dialysis Facility to a Non-Hospital-based Dialysis facility
GJ|OPT OUT PROVIDER OF ER SRVC
GK|ACTUAL ITEM/SERVICE ORDERED
GL|UPGRADED ITEM, NO CHARGE
GM|MULTIPLE TRANSPORTS
GN|Hospital-based Dialysis Facility to a Skilled Nursing Facility (SNF)
GN|OP SPEECH LANGUAGE SERVICE
GO|OP OCCUPATIONAL THERAPY SERV
GP|Hospital-based Dialysis Facility to a Physician's office
GP|OP PT SERVICES
GQ|TELEHEALTH STORE AND FORWARD
GR|Hospital-based Dialysis Facility to a Residence
GR|SERVICE BY VA RESIDENT
GS|Hospital-based Dialysis Facility to a Scene of Accident/Acute Event
GS|EPO/DARBEPOIETIN REDUCED 25%
GT|INTERACTIVE TELECOMMUNICATION
GU|LIABILITY WAIVER ROUT NOTICE
GV|ATTENDING PHYS NOT HOSPICE
GW|SERVICE UNRELATED TO TERM CO
GX|Hospital-based Dialysis Facility to an Intermediate Stop at Physician's Office
GX|VOLUNTARY LIABILITY NOTICE
GY|STATUTORILY EXCLUDED
GZ|NOT REASONABLE AND NECESSARY
H9|COURT-ORDERED
HA|CHILD/ADOLESCENT PROGRAM
HB|ADULT PROGRAM NON-GERIATRIC
HC|ADULT PROGRAM GERIATRIC
HD|Hospital to a Diagnostic/therapeutic site other than P/H
HD|PREGNANT/PARENTING PROGRAM
HE|Hospital to a Residential/Domiciliary/Custodial fac.
HE|MENTAL HEALTH PROGRAM
HF|SUBSTANCE ABUSE PROGRAM
HG|Hospital to a Hospital-based Dialysis Facility
HG|OPIOID ADDICTION TX PROGRAM
HH|Hospital to another Hospital
HH|MENTAL HLTH/SUBSTANCE ABS PR
HI|Hospital to a Site of ambulance transport modes transfer
HI|MEN HLTH INTEL/DEV DISAB PGM
HJ|Hospital to a Non-Hospital-based Dialysis facility
HJ|EMPLOYEE ASSISTANCE PROGRAM
HK|SPEC HIGH RSK MNTL HLTH POP P
HL|INTERN
HM|LESS THAN BACHELOR DEGREE LV
HN|Hospital to a Skilled Nursing Facility (SNF)
HN|BACHELORS DEGREE LEVEL
HO|MASTERS DEGREE LEVEL
HP|Hospital to a Physician's office
HP|DOCTORAL LEVEL
HQ|GROUP SETTING
HR|Hospital to a Residence
HR|FAMILY/COUPLE W CLIENT PRSNT
HS|Hospital to a Scene of Accident/Acute Event
HS|FAMILY/COUPLE W/O CLIENT PRSNT
HT|MULTI-DISCIPLINARY TEAM
HU|CHILD WELFARE AGENCY FUNDED
HV|FUNDED STATE ADDICTION AGNCY
HW|STATE MNTL HLTH AGNCY FUNDED
HX|Hospital to an Intermediate Stop at Physician's Office
HX|COUNTY/LOCAL AGENCY FUNDED
HY|FUNDED BY JUVENILE JUSTICE
HZ|CRIMINAL JUSTICE AGNCY FUND
ID|Site of ambulance transport modes transfer to a Diagnostic/therapeutic site other than P/H
IE|Site of ambulance transport modes transfer to a Residential/Domiciliary/Custodial fac.
IG|Site of ambulance transport modes transfer to a Hospital-based Dialysis Facility
IH|Site of ambulance transport modes transfer to a Hospital
II|Site of ambulance transport modes transfer to another Site of ambulance transport modes transfer
IJ|Site of ambulance transport modes transfer to a Non-Hospital-based Dialysis facility
IN|Site of ambulance transport modes transfer to a Skilled Nursing Facility (SNF)
IP|Site of ambulance transport modes transfer to a Physician's office
IR|Site of ambulance transport modes transfer to a Residence
IS|Site of ambulance transport modes transfer to a Scene of Accident/Acute Event
IX|Site of ambulance transport modes transfer to an Intermediate Stop at Physician's Office
J1|COMPETITIVE ACQUISITION PROGRAM NO-PAY SUBMISSION FOR A PRESCRIPTION NUMBER
J2|COMPETITIVE ACQUISITION PROGRAM, RESTOCKING OF EMERGENCY DRUGS AFTER EMERGENCY
J3|COMPETITIVE ACQUISITION PROGRAM (CAP), DRUG NOT AVAILABLE THROUGH CAP
J4|DMEPOS COMP BID FURN BY HOSP
JA|ADMINISTERED INTRAVENOUSLY
JB|ADMINISTERED SUBCUTANEOUSLY
JC|SKIN SUBSTITUTE USED AS A GRAFT
JD|Non-Hospital-based Dialysis facility to a Diagnostic/therapeutic site other than P/H
JD|SKIN SUBSTITUTE NOT USED AS A GRAFT
JE|Non-Hospital-based Dialysis facility to a Residential/Domiciliary/Custodial fac.
JE|ADMINISTERED VIA DIALYSATE
JF|COMPOUNDED DRUG
JG|Non-Hospital-based Dialysis facility to a Hospital-based Dialysis Facility
JH|Non-Hospital-based Dialysis facility to a Hospital
JI|Non-Hospital-based Dialysis facility to a Site of ambulance transport modes transfer
JJ|Non-Hospital-based Dialysis facility to another Non-Hospital-based Dialysis facility
JN|Non-Hospital-based Dialysis facility to a Skilled Nursing Facility (SNF)
JP|Non-Hospital-based Dialysis facility to a Physician's office
JR|Non-Hospital-based Dialysis facility to a Residence
JS|Non-Hospital-based Dialysis facility to a Scene of Accident/Acute Event
JW|DISCARDED DRUG NOT ADMINISTE
JX|Non-Hospital-based Dialysis facility to an Intermediate Stop at Physician's Office
K0|LWR EXT PROST FUNCTNL LVL 0
K1|LWR EXT PROST FUNCTNL LVL 1
K2|LWR EXT PROST FUNCTNL LVL 2
K3|LWR EXT PROST FUNCTNL LVL 3
K4|LWR EXT PROST FUNCTNL LVL 4
KA|WHEELCHAIR ADD-ON OPTION/ACC
KB|>4 MODIFIERS ON CLAIM
KC|REPL SPECIAL PWR WC INTRFACE
KD|DRUG/BIOLOGICAL DME INFUSED
KE|BID UNDER ROUND ONE OF THE DMEPOS COMPETITIVE BIDDING PROGRAM FOR USE WITH
KF|FDA CLASS III DEVICE
KG|DMEPOS ITEM SUBJECT TO DMEPOS COMPETITIVE BIDDING PROGRAM NUMBER 1
KH|DMEPOS INI CLM, PUR/1 MO RNT
KI|DMEPOS 2ND OR 3RD MO RENTAL
KJ|DMEPOS PEN PMP OR 4-15 MO RNT
KK|DMEPOS ITEM SUBJECT TO DMEPOS COMPETITIVE BIDDING PROGRAM NUMBER 2
KL|DMEPOS ITEM DELIVERED VIA MAIL
KM|RPLC FACIAL PROSTH NEW IMP
KN|RPLC FACIAL PROSTH OLD MOD
KO|SINGLE DRUG UNIT DOSE FORM
KP|FIRST DRUG OF MULTI DRUG U D
KQ|2ND/SUBSQNT DRG MULTI DRG UD
KR|RENTAL ITEM PARTIAL MONTH
KS|GLUCOSE MONITOR SUPPLY
KT|ITEM FROM NONCONTRACT SUPPLY
KU|DMEPOS ITEM SUBJECT TO DMEPOS COMPETITIVE BIDDING PROGRAM NUMBER 3
KV|DMEPOS ITEM, PROFESSION SERV
KW|DMEPOS ITEM SUBJECT TO DMEPOS COMPETITIVE BIDDING PROGRAM NUMBER 4
KX|DOCUMENTATION ON FILE
KY|DMEPOS ITEM SUBJECT TO DMEPOS COMPETITIVE BIDDING PROGRAM NUMBER 5
KZ|NEW COV NOT IMPLEMENT BY M+C
L1|SEPARATELY PAYABLE LAB TEST
LC|LFT CIRCUM CORONARY ARTERY
LD|LEFT ANT DES CORONARY ARTERY
LL|LEASE/RENTAL (APPLD TO PUR)
LM|LEFT MAIN CORONARY ARTERY
LR|LABORATORY ROUND TRIP
LS|FDA-MONITORED IOL IMPLANT
LT|LEFT SIDE
M2|MEDICARE SECONDARY PAYER (MSP)
MS|6-MO MAINT/SVC FEE PARTS/LBR
NB|DRUG SPECIFIC NEBULIZER
ND|Skilled Nursing Facility (SNF) to a Diagnostic/therapeutic site other than P/H
NE|Skilled Nursing Facility (SNF) to a Residential/Domiciliary/Custodial fac.
NG|Skilled Nursing Facility (SNF) to a Hospital-based Dialysis Facility
NH|Skilled Nursing Facility (SNF) to a Hospital
NI|Skilled Nursing Facility (SNF) to a Site of ambulance transport modes transfer
NJ|Skilled Nursing Facility (SNF) to a Non-Hospital-based Dialysis facility
NN|Skilled Nursing Facility (SNF) to another Skilled Nursing Facility (SNF)
NP|Skilled Nursing Facility (SNF) to a Physician's office
NR|Skilled Nursing Facility (SNF) to a Residence
NR|NEW WHEN RENTED
NS|Skilled Nursing Facility (SNF) to a Scene of Accident/Acute Event
NU|NEW EQUIPMENT
NX|Skilled Nursing Facility (SNF) to an Intermediate Stop at Physician's Office
P1|A NORMAL HEALTHY PATIENT
P2|A PATIENT WITH MILD SYSTEMIC DISEASE
P3|A PATIENT WITH SEVERE SYSTEMIC DISEASE
P4|A PATIENT WITH SEVERE SYSTEMIC DISEASE THAT IS A CONSTANT THREAT TO LIFE
P5|A MORIBUND PATIENT WHO IS NOT EXPECTED TO SURVIVE WITHOUT THE OPERATION
P6|A DECLARED BRAIN-DEAD PATIENT WHOSE ORGANS ARE BEING REMOVED FOR DONOR PURPOSES
PA|SURGERY, WRONG BODY PART
PB|SURGERY, WRONG PATIENT
PC|WRONG SURGERY ON PATIENT
PD|Physician's office to a Diagnostic/therapeutic site other than P/H
PD|INP ADMIT W/IN 3 DAYS
PE|Physician's office to a Residential/Domiciliary/Custodial fac.
PG|Physician's office to a Hospital-based Dialysis Facility
PH|Physician's office to a Hospital
PI|Physician's office to a Site of ambulance transport modes transfer
PI|PET TUMOR INIT TX STRAT
PJ|Physician's office to a Non-Hospital-based Dialysis facility
PL|PROGRESSIVE ADDITION LENSES
PM|POST MORTEM
PN|Physician's office to a Skilled Nursing Facility (SNF)
PO|SERV/PROC OFF-CAMPUS PBD
PP|Physician's office to another Physician's office
PR|Physician's office to a Residence
PS|Physician's office to a Scene of Accident/Acute Event
PS|PET TUMOR SUBSQ TX STRATEGY
PT|COLORECTAL CANCER SCREENING TEST, CONVERTED TO DIAGNOSTIC TEST OR OTHER PROCEDURE
PX|Physician's office to an Intermediate Stop at Physician's Office
Q0|INVESTIGATIONAL CLINICAL SERVICE PROVIDED IN A CLINICAL RESEARCH STUDY THAT IS
Q1|ROUTINE CLINICAL SERVICE PROVIDED IN A CLINICAL RESEARCH STUDY THAT IS IN AN
Q2|HCFA/ORD DEMO PROCEDURE/SVC
Q3|LIVER DONOR SURGERY/SERVICES
Q4|SVC EXEMPT-ORDRG/RFRNG MD
Q5|SUBST MD SVC, RECIP BILL ARR
Q6|LOCUM TENENS MD SERVICE
Q7|ONE CLASS A FINDING
Q8|TWO CLASS B FINDINGS
Q9|1 CLASS B & 2 CLASS C FNDNGS
QA|FDA INVESTIGATIONAL DEVICE
QB|MD PRVDG SVC IN RURAL HPSA
QC|SINGLE CHANNEL MONITORING
QD|RCRDG/STRG IN SLD ST MEMORY
QE|PRESCRIBED OXYGEN <1 LPM
QF|PRSCRBD OXYGEN >4 LPM & PORT
QG|PRESCRIBED OXYGEN >4 LPM
QH|OXYGEN CNSRVG DVC W DEL SYS
QJ|PATIENT IN STATE/LOCL CUSTOD
QK|MED DIR 2-4 CNCRNT ANES PROC
QL|PATIENT DIED AFTER AMB CALL
QM|AMBULANCE ARR BY PROVIDER
QN|AMBULANCE FURN BY PROVIDER
QP|INDIVIDUALLY ORDERED LAB TST
QQ|SOI SUBMITTED
QR|ITEM OR SERVICE PROVIDED IN A MEDICARE SPECIFIED STUDY
QS|MONITORED ANESTHESIA CARE
QT|RCRDG/STRG TAPE ANALOG RECDR
QU|MD PROVIDING SVC URBAN HPSA
QV|ITEM OR SERVICE PROVIDED
QW|CLIA WAIVED TEST
QX|CRNA SVC W/ MD MED DIRECTION
QY|MEDICALLY DIRECTED CRNA
QZ|CRNA SVC W/O MED DIR BY MD
RA|REPLACEMENT OF A DME ITEM
RB|REPLACEMENT OF A PART OF DME FURNISHED AS PART OF A REPAIR
RC|RIGHT CORONARY ARTERY
RD|Residence to a Diagnostic/therapeutic site other than P/H
RD|DRUG ADMIN NOT INCIDENT-TO
RE|Residence to a Residential/Domiciliary/Custodial fac.
RE|FURNISHED IN FULL COMPLIANCE WITH FDA-MANDATED RISK EVALUATION AND MITIGATION
RG|Residence to a Hospital-based Dialysis Facility
RH|Residence to a Hospital
RI|Residence to a Site of ambulance transport modes transfer
RI|RAMUS INTERMEDIUS CORONARY ARTERY
RJ|Residence to a Non-Hospital-based Dialysis facility
RN|Residence to a Skilled Nursing Facility (SNF)
RP|Residence to a Physician's office
RP|REPLACEMENT & REPAIR(DMEPOS)
RR|Residence to another Residence
RR|RENTAL(DME)
RS|Residence to a Scene of Accident/Acute Event
RT|RIGHT SIDE
RX|Residence to an Intermediate Stop at Physician's Office
SA|NURSE PRACTITIONER W PHYSICI
SB|NURSE MIDWIFE
SC|MEDICALLY NECESSARY SERV/SUP
SD|Scene of Accident/Acute Event to a Diagnostic/therapeutic site other than P/H
SD|SERV BY HOME INFUSION RN
SE|Scene of Accident/Acute Event to a Residential/Domiciliary/Custodial fac.
SE|STATE/FED FUNDED PROGRAM/SER
SF|2ND OPINION ORDERED BY PRO
SG|Scene of Accident/Acute Event to a Hospital-based Dialysis Facility
SG|ASC FACILITY SERVICE
SH|Scene of Accident/Acute Event to a Hospital
SH|2ND CONCURRENT INFUSION THER
SI|Scene of Accident/Acute Event to a Site of ambulance transport modes transfer
SJ|Scene of Accident/Acute Event to a Non-Hospital-based Dialysis facility
SJ|3RD CONCURRENT INFUSION THER
SK|HIGH RISK POPULATION
SL|STATE SUPPLIED VACCINE
SM|SECOND OPINION
SN|Scene of Accident/Acute Event to a Skilled Nursing Facility (SNF)
SN|THIRD OPINION
SP|Scene of Accident/Acute Event to a Physician's office
SQ|ITEM ORDERED BY HOME HEALTH
SR|Scene of Accident/Acute Event to a Residence
SS|Scene of Accident/Acute Event to another Scene of Accident/Acute Event
SS|HOME INFUSION SERVICES PROVIDED IN THE INFUSION SUITE OF THE IV THERAPY PROVIDER
ST|RELATED TO TRAUMA OR INJURY
SU|PERFORMED IN PHYS OFFICE
SV|DRUGS DELIVERED NOT USED
SW|SERV BY CERT DIAB EDUCATOR
SX|Scene of Accident/Acute Event to an Intermediate Stop at Physician's Office
SY|CONTACT W/HIGH-RISK POP
SZ|HABILITATIVE SERVICES
T1|LEFT FOOT, SECOND DIGIT
T2|LEFT FOOT, THIRD DIGIT
T3|LEFT FOOT, FOURTH DIGIT
T4|LEFT FOOT, FIFTH DIGIT
T5|RIGHT FOOT, GREAT TOE
T6|RIGHT FOOT, SECOND DIGIT
T7|RIGHT FOOT, THIRD DIGIT
T8|RIGHT FOOT, FOURTH DIGIT
T9|RIGHT FOOT, FIFTH DIGIT
TA|LEFT FOOT, GREAT TOE
TC|TECHNICAL COMPONENT
TD|RN
TE|LPN/LVN
TF|INTERMEDIATE LEVEL OF CARE
TG|COMPLEX/HIGH TECH LEVEL CARE
TH|OB TX/SRVCS PRENATL/POSTPART
TJ|CHILD/ADOLESCENT PROGRAM GP
TK|EXTRA PATIENT OR PASSENGER
TL|EARLY INTERVENTION IFSP
TM|INDIVIDUALIZED ED PRGRM(IEP)
TN|RURAL/OUT OF SERVICE AREA
TP|MED TRANSPRT UNLOADED VEHICL
TQ|BLS BY VOLUNTEER AMB PROVIDR
TR|SCHOOL-BASED IEP OUT OF DIST
TS|FOLLOW-UP SERVICE
TT|ADDITIONAL PATIENT
TU|OVERTIME PAYMENT RATE
TV|HOLIDAY/WEEKEND PAYMENT RATE
TW|BACK-UP EQUIPMENT
U1|M/CAID CARE LEV 1 STATE DEF
U2|M/CAID CARE LEV 2 STATE DEF
U3|M/CAID CARE LEV 3 STATE DEF
U4|M/CAID CARE LEV 4 STATE DEF
U5|M/CAID CARE LEV 5 STATE DEF
U6|M/CAID CARE LEV 6 STATE DEF
U7|M/CAID CARE LEV 7 STATE DEF
U8|M/CAID CARE LEV 8 STATE DEF
U9|M/CAID CARE LEV 9 STATE DEF
UA|M/CAID CARE LEV 10 STATE DEF
UB|M/CAID CARE LEV 11 STATE DEF
UC|M/CAID CARE LEV 12 STATE DEF
UD|M/CAID CARE LEV 13 STATE DEF
UE|USED DURABLE MED EQUIPMENT
UF|SERVICES PROVIDED, MORNING
UG|SERVICES PROVIDED, AFTERNOON
UH|SERVICES PROVIDED, EVENING
UJ|SERVICES PROVIDED, NIGHT
UK|SVC ON BEHALF CLIENT-COLLAT
UN|TWO PATIENTS SERVED
UP|THREE PATIENTS SERVED
UQ|FOUR PATIENTS SERVED
UR|FIVE PATIENTS SERVED
US|SIX OR MORE PATIENTS SERVED
V5|VASCULAR CATHETER
V6|ARTERIOVENOUS GRAFT
V7|ARTERIOVENOUS FISTULA
V8|INFECTION PRESENT
V9|NO INFECTION PRESENT
VP|APHAKIC PATIENT
XE|SEPARATE ENCOUNTER
XP|SEPARATE PRACTITIONER
XS|SEPARATE ORGAN/STRUCTURE
XU|UNUSUAL SEPARATE SERVICE
ZA|NOVARTIS/SANDOZ
